CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain
CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unkno...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2014-03, Vol.289 (10), p.6969-6977 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6977 |
---|---|
container_issue | 10 |
container_start_page | 6969 |
container_title | The Journal of biological chemistry |
container_volume | 289 |
creator | Hou, Shengke Ge, Kuikui Zheng, Xiaodong Wei, Haiming Sun, Rui Tian, Zhigang |
description | CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.
Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity.
Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells.
Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein.
Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands. |
doi_str_mv | 10.1074/jbc.M113.498253 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820445144</els_id><sourcerecordid>1521330960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-6f9294019bb26c23f447ae0f98f633ed533c8d850d348655c7c5f6cf9e1b974a3</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi0EokNhzQ55WRaZ-jcTb5CqaaeMWgoSRWJnOc7N4CqxB9uJ6CP0rckopYIF3liWz_3utQ9CbylZUrISp3e1XX6ilC-Fqpjkz9CCkooXXNLvz9GCEEYLxWR1hF6ldEemJRR9iY6YEJLyFV2gh_U5YyX-EkMG5_E24a0fQzdCgw_Hvh884K_33uwT4E2IvckueGx8g2-j2-0gJnxj8hBNh69c10HEJzdX7_Eaug6f2ezGuWB0Bm9zwhsXU8YXv3I0dkKGzkR8Hnrj_Gv0ojVdgjeP-zH6trm4XX8srj9fbtdn14UVgueibBVTglBV16y0jLdCrAyQVlVtyTk0knNbNZUkDRdVKaVdWdmWtlVAa7UShh-jD3Pufqh7aCz4aZZO76PrTbzXwTj97413P_QujJorIbmspoCTx4AYfg6Qsu5dOjzGeAhD0lQyyjlRJZnQ0xm1MaQUoX1qQ4k-CNSTQH0QqGeBU8W7v6d74v8YmwA1AzD90egg6mQdeAuNi2CzboL7b_hv-yyrIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521330960</pqid></control><display><type>article</type><title>CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Hou, Shengke ; Ge, Kuikui ; Zheng, Xiaodong ; Wei, Haiming ; Sun, Rui ; Tian, Zhigang</creator><creatorcontrib>Hou, Shengke ; Ge, Kuikui ; Zheng, Xiaodong ; Wei, Haiming ; Sun, Rui ; Tian, Zhigang</creatorcontrib><description>CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.
Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity.
Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells.
Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein.
Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M113.498253</identifier><identifier>PMID: 24451371</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Animals ; Antigens, Differentiation, T-Lymphocyte - chemistry ; Antigens, Differentiation, T-Lymphocyte - genetics ; Antigens, Differentiation, T-Lymphocyte - metabolism ; CD55 Antigens - metabolism ; Cell Biology ; Cell Junctions ; CHO Cells ; Cricetulus ; Cytotoxicity, Immunologic ; ERK ; HeLa Cells ; Humans ; Immunological Synapses - metabolism ; Immunological Synapses - physiology ; Immunology ; K562 Cells ; Killer Cells, Natural - immunology ; Lymphocyte Activation ; Molecular Sequence Data ; Natural Killer (NK) Cell ; Phosphorylation ; Protein Structure, Tertiary ; Recombinant Proteins - chemistry ; Recombinant Proteins - genetics ; Recombinant Proteins - metabolism ; Surface Plasmon Resonance</subject><ispartof>The Journal of biological chemistry, 2014-03, Vol.289 (10), p.6969-6977</ispartof><rights>2014 © 2014 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2014 by The American Society for Biochemistry and Molecular Biology, Inc. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-6f9294019bb26c23f447ae0f98f633ed533c8d850d348655c7c5f6cf9e1b974a3</citedby><cites>FETCH-LOGICAL-c443t-6f9294019bb26c23f447ae0f98f633ed533c8d850d348655c7c5f6cf9e1b974a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945358/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945358/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24451371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hou, Shengke</creatorcontrib><creatorcontrib>Ge, Kuikui</creatorcontrib><creatorcontrib>Zheng, Xiaodong</creatorcontrib><creatorcontrib>Wei, Haiming</creatorcontrib><creatorcontrib>Sun, Rui</creatorcontrib><creatorcontrib>Tian, Zhigang</creatorcontrib><title>CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.
Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity.
Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells.
Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein.
Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antigens, Differentiation, T-Lymphocyte - chemistry</subject><subject>Antigens, Differentiation, T-Lymphocyte - genetics</subject><subject>Antigens, Differentiation, T-Lymphocyte - metabolism</subject><subject>CD55 Antigens - metabolism</subject><subject>Cell Biology</subject><subject>Cell Junctions</subject><subject>CHO Cells</subject><subject>Cricetulus</subject><subject>Cytotoxicity, Immunologic</subject><subject>ERK</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Immunological Synapses - metabolism</subject><subject>Immunological Synapses - physiology</subject><subject>Immunology</subject><subject>K562 Cells</subject><subject>Killer Cells, Natural - immunology</subject><subject>Lymphocyte Activation</subject><subject>Molecular Sequence Data</subject><subject>Natural Killer (NK) Cell</subject><subject>Phosphorylation</subject><subject>Protein Structure, Tertiary</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - metabolism</subject><subject>Surface Plasmon Resonance</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURi0EokNhzQ55WRaZ-jcTb5CqaaeMWgoSRWJnOc7N4CqxB9uJ6CP0rckopYIF3liWz_3utQ9CbylZUrISp3e1XX6ilC-Fqpjkz9CCkooXXNLvz9GCEEYLxWR1hF6ldEemJRR9iY6YEJLyFV2gh_U5YyX-EkMG5_E24a0fQzdCgw_Hvh884K_33uwT4E2IvckueGx8g2-j2-0gJnxj8hBNh69c10HEJzdX7_Eaug6f2ezGuWB0Bm9zwhsXU8YXv3I0dkKGzkR8Hnrj_Gv0ojVdgjeP-zH6trm4XX8srj9fbtdn14UVgueibBVTglBV16y0jLdCrAyQVlVtyTk0knNbNZUkDRdVKaVdWdmWtlVAa7UShh-jD3Pufqh7aCz4aZZO76PrTbzXwTj97413P_QujJorIbmspoCTx4AYfg6Qsu5dOjzGeAhD0lQyyjlRJZnQ0xm1MaQUoX1qQ4k-CNSTQH0QqGeBU8W7v6d74v8YmwA1AzD90egg6mQdeAuNi2CzboL7b_hv-yyrIg</recordid><startdate>20140307</startdate><enddate>20140307</enddate><creator>Hou, Shengke</creator><creator>Ge, Kuikui</creator><creator>Zheng, Xiaodong</creator><creator>Wei, Haiming</creator><creator>Sun, Rui</creator><creator>Tian, Zhigang</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140307</creationdate><title>CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain</title><author>Hou, Shengke ; Ge, Kuikui ; Zheng, Xiaodong ; Wei, Haiming ; Sun, Rui ; Tian, Zhigang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-6f9294019bb26c23f447ae0f98f633ed533c8d850d348655c7c5f6cf9e1b974a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antigens, Differentiation, T-Lymphocyte - chemistry</topic><topic>Antigens, Differentiation, T-Lymphocyte - genetics</topic><topic>Antigens, Differentiation, T-Lymphocyte - metabolism</topic><topic>CD55 Antigens - metabolism</topic><topic>Cell Biology</topic><topic>Cell Junctions</topic><topic>CHO Cells</topic><topic>Cricetulus</topic><topic>Cytotoxicity, Immunologic</topic><topic>ERK</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Immunological Synapses - metabolism</topic><topic>Immunological Synapses - physiology</topic><topic>Immunology</topic><topic>K562 Cells</topic><topic>Killer Cells, Natural - immunology</topic><topic>Lymphocyte Activation</topic><topic>Molecular Sequence Data</topic><topic>Natural Killer (NK) Cell</topic><topic>Phosphorylation</topic><topic>Protein Structure, Tertiary</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - metabolism</topic><topic>Surface Plasmon Resonance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hou, Shengke</creatorcontrib><creatorcontrib>Ge, Kuikui</creatorcontrib><creatorcontrib>Zheng, Xiaodong</creatorcontrib><creatorcontrib>Wei, Haiming</creatorcontrib><creatorcontrib>Sun, Rui</creatorcontrib><creatorcontrib>Tian, Zhigang</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hou, Shengke</au><au>Ge, Kuikui</au><au>Zheng, Xiaodong</au><au>Wei, Haiming</au><au>Sun, Rui</au><au>Tian, Zhigang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2014-03-07</date><risdate>2014</risdate><volume>289</volume><issue>10</issue><spage>6969</spage><epage>6977</epage><pages>6969-6977</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.
Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity.
Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells.
Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein.
Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24451371</pmid><doi>10.1074/jbc.M113.498253</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2014-03, Vol.289 (10), p.6969-6977 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945358 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Amino Acid Sequence Animals Antigens, Differentiation, T-Lymphocyte - chemistry Antigens, Differentiation, T-Lymphocyte - genetics Antigens, Differentiation, T-Lymphocyte - metabolism CD55 Antigens - metabolism Cell Biology Cell Junctions CHO Cells Cricetulus Cytotoxicity, Immunologic ERK HeLa Cells Humans Immunological Synapses - metabolism Immunological Synapses - physiology Immunology K562 Cells Killer Cells, Natural - immunology Lymphocyte Activation Molecular Sequence Data Natural Killer (NK) Cell Phosphorylation Protein Structure, Tertiary Recombinant Proteins - chemistry Recombinant Proteins - genetics Recombinant Proteins - metabolism Surface Plasmon Resonance |
title | CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A03%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD226%20Protein%20Is%20Involved%20in%20Immune%20Synapse%20Formation%20and%20Triggers%20Natural%20Killer%20(NK)%20Cell%20Activation%20via%20Its%20First%20Extracellular%20Domain&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Hou,%20Shengke&rft.date=2014-03-07&rft.volume=289&rft.issue=10&rft.spage=6969&rft.epage=6977&rft.pages=6969-6977&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M113.498253&rft_dat=%3Cproquest_pubme%3E1521330960%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521330960&rft_id=info:pmid/24451371&rft_els_id=S0021925820445144&rfr_iscdi=true |